Thymmune Therapeutics

Biotech firm developing thymic cell therapies to restore immune function using machine learning

Founded 2019

Cambridge, United States 26 employees Seed Total: $44.30M Biotechnology, Health and Wellness

General Information

Company Name Thymmune Therapeutics

Founded Year 2019

Location

Cambridge, United States

Employees 26

Industries Biotechnology, Health and Wellness

Funding Stage Seed

Business Model B2B, B2D, Platform

Revenue Model Product Sales, Licensing, Service Fee

Social

BounceWatch is an independent company data service, not affiliated with Thymmune Therapeutics. To contact Thymmune Therapeutics, visit thymmune.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Thymmune Therapeutics compare?

A PDF of Thymmune Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Thymmune Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is Thymmune Therapeutics on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

United States Market

Market Signals All Companies

Biotechnology

Industry Signals All Companies in United States

Thymmune Therapeutics Alternatives

All Signals Trend Reports

About Thymmune Therapeutics

Thymmune Therapeutics, a Cambridge, MA-based biotech firm, is pioneering in the realm of thymic cell therapies with an innovative use of machine learning to restore immune function. Founded in 2019, the company focuses on developing a unique platform that utilizes iPSC-thymic cell manufacturing to produce scalable, off-the-shelf cell solutions. This positions them at the forefront of tackling complex medical challenges related to immunodeficiencies, transplant complications, and autoimmune diseases.

The recent $37.00M in grant funding led by the Advanced Research Projects Agency for Health on 29 September 2023 underscores the strong interest and confidence in Thymmune's potential. Operating in the Biotechnology and Health and Wellness sectors, Thymmune's strategic emphasis on combining cutting-edge technology with practical therapeutic solutions makes it a significant contender in healthcare innovation.

Business keywords: Thymic Cell Therapies, iPSC Manufacturing, Immunotherapy, Immune Restoration, Aging, Disease Treatment, Immunodeficiencies, Transplant Therapeutics, Autoimmune Diseases, Cell Engineering, Off-the-shelf Therapies, Therapeutic Pipeline, Biotech Innovation

Services & Products

Development of thymic cell engineering platform

Mass production of iPSC-derived thymic cells

Research and development of therapies for immune disorders

Preclinical studies of thymic cell therapy

Therapeutic development for healthy immune aging

Target Customers

Patients with immune-mediated diseases Individuals with immunodeficiencies Patients experiencing age-related immune decline Healthcare professionals seeking innovative treatments

Funding Rounds & Investors (3)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$37.00M	1	Advanced Research Projects Agency for Health (ARPA-H)	01 Sep 2023
Seed	$7.00M	8	Pillar, Forth Management +6	01 Mar 2023
Grant	$300.00K	-		01 Apr 2022

Thymmune Therapeutics Alternatives & Competitors

View All Alternatives

Thymmune Therapeutics vs

Fate Therapeutics Inc. United States

Transforming the lives of patients with autoimmune diseases and cancer.

227 employees

Biotechnology, Health Care

Compare Thymmune Therapeutics vs Fate Therapeutics Inc.

Thymmune Therapeutics vs

RemedyBio Ireland

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of immune and di...

Venture round

7 employees

Biotechnology, Health and Wellness

Compare Thymmune Therapeutics vs RemedyBio

Thymmune Therapeutics vs

Repertoire Immune Medicines United States

Repertoire is a biotechnology company creating a new category of immune medicines for cancer and aut...

Series B

86 employees

Biotechnology, Health and Wellness

View all alternatives

FAQ About Thymmune Therapeutics

Biotech firm developing thymic cell therapies to restore immune function using machine learning

Thymmune Therapeutics was founded in 2019.

Thymmune Therapeutics is headquartered in Cambridge, United States.

Thymmune Therapeutics operates in Biotechnology and Health and Wellness. Its work centres on Thymic Cell Therapies, iPSC Manufacturing, Immunotherapy and Immune Restoration. Its customers include Patients with immune-mediated diseases, Individuals with immunodeficiencies and Patients experiencing age-related immune decline.

Thymmune Therapeutics has a B2B, B2D and Platform business model. Its revenue comes from Product Sales, Licensing and Service Fee.

Thymmune Therapeutics has approximately 26 employees.

Thymmune Therapeutics has completed 3 funding rounds, raising a total of $44.30M. The latest funding stage is Seed.

Thymmune Therapeutics offers: Development of thymic cell engineering platform, Mass production of iPSC-derived thymic cells, Research and development of therapies for immune disorders, Preclinical studies of thymic cell therapy, Therapeutic development for healthy immune aging.

Top alternatives and competitors to Thymmune Therapeutics include Fate Therapeutics Inc., RemedyBio, Repertoire Immune Medicines, Longeveron Inc, Tessa Therapeutics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Thymmune Therapeutics and Fate Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Thymmune Therapeutics, https://bouncewatch.com/company/thymmune-therapeutics, updated 4 March 2026. When citing, please name BounceWatch and link this page.